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Abstract
The platelet and megakaryocyte cytoskeletons are essential for formation and function of these
cells. A dynamic, properly organised tubulin and actin cytoskeleton is critical for the develop-
ment of the megakaryocyte and the extension of proplatelets. Tubulin in particular plays a
pivotal role in the extension of these proplatelets and the release of platelets from them.
Tubulin is further required for the maintenance of platelet size, and actin is the driving force for
shape change, spreading and platelet contraction during platelet activation. Whilst several key
proteins which regulate these cytoskeletons have been described in detail, the formin family of
proteins has received less attention. Formins are intriguing as, although they were initially
believed to simply be a nucleator of actin polymerisation, increasing evidence shows they are
important regulators of the crosstalk between the actin and microtubule cytoskeletons. In this
review, we will introduce the formin proteins and consider the recent evidence that they play
an important role in platelets and megakaryocytes in mediating both the actin and tubulin
cytoskeletons.
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Formins
Actin filament nucleation and elongation
Formin proteins were first identified in mice from studies on
abnormal limb development (1,2) with homologues subsequently
being found in drosophila and yeast (3). A list of the formin
proteins expressed in mammalian cells is given in Table I.
Formins have the ability to both nucleate and accelerate the
elongation of linear actin filaments. They play a crucial role in
the assembly of cytoskeletal structures such as filopodia, lamelli-
podia and stress fibres and are therefore required for a range of
cellular processes including cell adhesion, cell division and cell
motility (4). These multidomain proteins are defined by the pre-
sence of highly conserved Formin Homology 1 (FH1) and Formin
Homology 2 (FH2) domains and a less well-conserved FH3
domain (Figure 1(a)). Formins function as a homodimer with
dimerisation mediated via the dimerisation domain (DD), a com-
ponent of the FH3 domain (5) and the FH2 domains (Figure 1(b)).
The FH2 domains form a doughnut-shaped head-to-tail dimer
which nucleates actin filaments. Indeed, it has been shown that
the FH2 domains alone are sufficient for actin filament nucleation
probably via the stabilisation of spontaneously formed actin
dimers (6). The FH2 domain remains processively attached to
actin filament barbed ends facilitating addition of actin monomers
to support elongation and shielding the filament from abundant
capping proteins (7–9). The FH1 domains recruit profilin bound
G-actin molecules, bringing them into close proximity with the
barbed end and thus accelerating filament elongation (10)
(Figure 1(c)).
Activation of formin proteins
Formin proteins exist in an auto-inhibited state. Diaphanous-
related formins (DRFs) contain conserved regulatory domains; a
C-terminal Diaphanous Auto-regulatory Domain (DAD) and an
N-terminal Diaphanous Inhibitory Domain (DID – which forms
part of the FH3 domain) (11). Intramolecular interactions
between the DAD and DID lead to auto-inhibition of formin
activity (Figure 1(d)). As a general rule, this auto-inhibition can
be relieved upon the interaction of the GTPase-binding domain
(GBD) with an active Rho GTPase (12). Therefore, Rho GTPases
recruit formins to different locations within the cell for localised
actin filament assembly.
DIAP1 (also known as DIAPH1, but commonly known as
mDia1) is the most studied formin and was found as an effector
of the small GTPase RhoA in the formation of actin stress fibres
(13). In its active form, it is a potent actin nucleator and accel-
erates filament elongation. mDia1 is activated as described above
by GTP bound Rho GTPase binding to the GBD causing displa-
cement of the DAD domain from the N terminal region of mDia1.
However, other members of the formin protein family show
different mechanisms of DAD release; for example, DAAM1 is
activated when the PDZ domain of the Dishevelled (Dvl) protein
binds to the DAD domain rather than by Rho binding (14).
Color versions of one or more of the figures in the article can be found
online at www.tandfonline.com/iplt.
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Similarly, although FHOD1 is recruited to the plasma membrane
by active Rac1 binding, this formin seems not to be activated by
GTPase interactions. Instead the auto-inhibitory state is disturbed
by the phosphorylation of residues in its DAD domain by Rho
effector kinase ROCK (15) and cGMP-dependent protein kinase 1
(PRKG1) (16).
Differences also exist in the activity and functions of indivi-
dual formins in cells. In comparison with mDia1, FHOD1 is less
effective at processively elongating actin filaments, but rather acts
as an actin bundling factor while protecting filaments from depo-
lymerisation (17,18). INF2 has a Wiskott–Aldrich syndrome
homology region 2 (WH2) domain which replaces the DAD
Table I. Mammalian formin proteins and their abundance in human and mouse platelets.
Full protein name
Abb. protein
name1
Human
Uniprot ID2
Mouse
Uniprot ID2
Copies per
human
platelet3
Copies per
mouse
platelet4
Human platelet
transcript
abundance5, 6
Mouse platelet
transcript
abundance5, 6
Dishevelled-associated
activator
of morphogenesis 1
DAAM1 Q9Y4D1 Q8BPM0 3800 8,529 3.53 6.47
Dishevelled-associated
activator of
morphogenesis 2
DAAM2 Q86T65 Q80U19 ND ND 0.04 0.00
Protein diaphanous
homolog 1
DIAP1
(mDia1)
O60610 O08808 8100 14,408 92.77 55.13
Protein diaphanous
homolog 2
DIAP2
(mDia2)
O60879 O70566 ND ND 0.11 0.02
Protein diaphanous
homolog 3
DIAP3
(mDia3)
Q9NSV4 Q9Z207 ND ND 0.04 0.06
FH2 domain-containing
protein 1
FHDC1 Q9C0D6 Q3ULZ2 ND ND 0.02 0.13
FH1/FH2 domain-
containing protein 1
FHOD1 Q9Y613 Q6P9Q4 7500 21,598 7.84 2.71
FH1/FH2 domain-
containing protein 3
FHOD3 Q2V2M9 Q76LL6 ND ND 0.00 0.00
Formin-1 FMN1 Q68DA7 Q05860 ND ND 0.03 0.00
Formin-2 FMN2 Q9NZ56 Q9JL04 ND ND 0.00 0.00
Formin-like protein 1 FMNL1 O95466 Q9JL26 ND ND 4.73 0.02
Formin-like protein 2 FMNL2 Q96PY5 A2APV2 ND ND 0.09 0.00
Formin-like protein 3 FMNL3 Q8IVF7 Q6ZPF4 ND 34 0.91 2.41
Delphilin Delphilin A4D2P6 Q0QWG9 ND ND 0.00 0.00
Inverted formin-2 INF2 Q27J81 E9QLA5 6600 14,269 99.89 162.86
1Abbreviated protein names taken from Uniprot and used in this review. Name in brackets is the commonly used name which we used in this review
2http://www.uniprot.org/
3Data from Burkhart et al. (34)
4Data from Zeiler et al. (38)
5Data from Rowley et al. (37)
6Mean RPKM (Reads Per Kilobase of transcript per Million mapped reads)
Figure 1. Generalised schematic of formin
domains and structures.a) Typical domains pre-
sent in members of the formin family and bind-
ing sites for proteins which interact with
formins. GBD = GTPase binding domain,
DID = diaphanous inhibitory domain,
DD = dimerisation domain, FH1 = formin
homology 1, FH2 = formin homology 2,
FH3 = formin homology 3, DAD = diaphanous
auto-regulatory domain. b) The homodimer is
formed through interactions of the DD and FH2
domains on each half of the dimer with auto-
inhibition being achieved by interaction of the
DAD with DID domains (blue dashed line). c)
The active conformation is achieved following
binding of GTP-bound Rho GTPases to the
GBD, via binding to dishevelled (Dvl)
(DAAM1) or Rho kinase mediated phosphory-
lation at Thr1141 (FHOD1). d) Formins nucleate
linear actin filaments by binding of dimerised
FH2 domains to actin dimers. Elongation of the
filament occurs via processive capping; the
binding of profilin:ATP G-actin to the FH1
domain allows the formin to facilitate addition
of actin monomers to the growing actin filament
whilst protecting it from capping proteins and
depolymerisation. Figure adapted from (11,68).
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found in the DRFs and is able to bind monomeric actin.
Interestingly, INF2 is able to sever filaments and accelerate
actin filament depolymerisation on the pointed end by virtue of
its WH2 domain, as well as to nucleate and elongate actin via its
FH2 domain. The switch between polymerisation and depolymer-
isation activity is thought to be mediated by the hydrolysis of
bound ATP within actin subunits upon addition to a filament and
the subsequent release of phosphate (19,20).
Microtubule organisation and dynamics
In addition to actin filament assembly, formins regulate micro-
tubule organisation and dynamics, providing a means of crosstalk
between the two cytoskeletons. Initial evidence for this came
from studies whereby activation of endogenous mDia1 by over-
expression of a DAD domain led to a stabilisation of microtubules
(21). mDia1 has been shown to interact with microtubules
through its FH2 domain. This interaction is via both direct bind-
ing to microtubules and through the microtubule plus end tracking
proteins EB1, APC 100 and CLIP170 (22). Henty-Ridilla et al.
found that CLIP170 increased the elongation rate of actin fila-
ments assembled by formins including DAAM1 and INF2 and
that a complex of mDia1/CLIP170 and EB1 triggered accelerated
actin polymerisation from microtubule plus ends (23). The
strength and effects of interactions between FH2 domains and
microtubules vary depending upon the source of the FH2 domain.
For example, the FH2 domain from mDia2 binds with a 1:1
stoichiometry to tubulin whereas that from INF2 and mDia1
binds with a 1:3 stoichiometry (24). In addition, binding of
microtubules to mDia2 FH2 domains strongly inhibits actin poly-
merisation where binding has no effect of INF2 FH2 domains
(24). Furthermore, DAAM1 can bind to both actin and micro-
tubules simultaneously linking actin polymerisation to regions of
stable microtubules (25) and co-alignment of actin filaments and
microtubules is observed when active fragments of mDia1 and
FHOD1 are expressed (26,27). Microtubule stability can also be
regulated by post-translational modification of alpha tubulin via
acetylation and detyrosination (28,29), and it has been demon-
strated that FH1-FH2 domains from the majority of formin
proteins can induce the formation of stabilised microtubules
through these post-translational modifications (30,31). Finally,
although it has been shown that regulation of microtubule stabi-
lity by formins can be independent of their actin polymerisation
activity (30), it is likely that in vivo these functions are closely
coordinated. Indeed, more recently, it has been suggested that
different formins could work in series or in collaboration to
regulate microtubule stability or actin assembly as evidenced for
mDia1 and INF2 (32). The proposed role of formins in actin and
microtubule organisation is summarised in Figure 2.
Expression of formins in megakaryocytes and platelets
In mammals, the family of formin proteins contains 15 members
which are subdivided into eight groups based on their protein
domain architecture. The formins vary in their localisation, bind-
ing partners and regulation, and show differences in the strength
and efficiency of their actin nucleation and elongation activity
(11) indicating that they may play many specialised roles in
different cell types. Of these 15 formins only a subset are
expressed in platelets and megakaryocytes.
Thomas et al. had previously reported on formin expression in
platelet and megakaryocytes using SAGE and Haematlas data-
bases (33). Since this time, further studies and advances in tech-
nology have allowed for more accurate measurements of the
formins at both the gene and protein expression level in platelets
and megakaryocytes (34–38). In these genomic and proteomic
studies, the expression profile of the mammalian formin proteins
changes over the developmental time course of the megakaryo-
cyte. In humans, expression of all formin proteins is low in CD34
+ progenitor cells. Over the course of progenitor cell commitment
to the megakaryocyte lineage and differentiation into mature
cells, the formins DAAM1, DIAPH1 (mDia1) and FHOD1 all
significantly increase their expression (Figure 3(a)). A similar
pattern is observed in mouse cells with a few differences
(Figure 3(b)), i). Fmnl3 appears highly expressed in the LT- and
ST-HSC and its expression decreases during differentiation – in
mature megakaryocytes, there is still some expression of this
formin, ii) there appears to be a small increase in expression of
Figure 2. Mechanisms of actin and microtubule regulation and coordination by formins.Formins are proposed to have direct and indirect actions on
actin filaments and microtubules. 1. Actin nucleation and elongation by formins occurs by processive capping of linear actin filaments. 2. Formins also
bundle actin filaments together and 3 align them with microtubules. 4, 5. Formins can bind to and stabilise microtubules directly or via interaction with
capping proteins including EB1. 6. Like for actin filaments, microtubules can also be brought in close proximity to each other by bundling regulated by
formins. Figure adapted from (69,70).
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Fhdc1 in maturing mouse megakaryocytes and iii) Inf2 increases
in its expression during differentiation.
In platelets, studies have used mass spectrometry-based pro-
teomics and RNA transcript abundance to assess the levels of the
formin proteins in human and mouse platelets (Table I). In human
platelets, DAAM1, mDia1 and FHOD1 are all found at the
protein level, matching closely the gene expression data from
megakaryocytes. However, interestingly, INF2 is also found in
human platelets despite no expression being reported in megakar-
yocytes and there is no evidence for mDia2 expression in human
platelets even though it has been shown previously by immuno-
precipitation and Western blot (33). This protein expression pat-
tern is also reflected in the RNA transcript abundance in the
platelets, with the addition of RNA transcripts for Fmnl1 being
observed, despite no evidence for expression at the gene of
proteins level in studies in developing megakaryocytes and
platelets.
In mouse platelets, again DAAM1, mDia1 and FHOD1 are all
found to be expressed along with INF2, which in this case
matches the megakaryocyte expression data. This pattern is
repeated for the platelet RNA transcript levels. A very small
amount of Fmnl3 protein and transcript is reported and this is
likely to be a carry over as this formin is expressed early in
differentiation. Taken all together, data from the genomics, pro-
teomics and other studies indicate that DAAM1, mDia1 and
FHOD1 are the major formin proteins in platelets, with a pre-
viously unidentified expression of INF2, particularly in mouse
platelets. The presence of mDia2 in human platelets is unclear.
Roles of formin proteins in megakaryocytes and
platelets
The formins mDia1 and DAAM1 were first identified in human
platelets by RhoA affinity chromatography with the affinity for
active RhoA (RhoA-GTP) being approximately 100× (mDia1)
and 200× (DAAM1) higher than for inactive RhoA (RhoA-
GDP). Both formins were shown to associate with RhoA in
platelets activated with thrombin and were both able to initiate
actin polymerisation in platelet lysates (39). Subsequently, it
was shown that mDia1 moved to the cytoskeleton (Triton
insoluble fraction) in activated platelets in a PI3-kinase
dependent manner (40). Work by Steele et al. studying Wnt3a
signalling in platelets has demonstrated that DAAM1 associ-
ates with dishevelled (Dvl), an effector of Wnt signalling, upon
activation by TRAP and therefore may be important in the
activation of RhoA via RhoGef recruitment (41). Thomas
et al. also identified that FHOD1 was activated in mouse and
human platelets downstream of various platelet agonists in a
Rho Kinase (ROCK) dependent and Rac1 independent man-
ner (33).
mDia1 function in platelets and megakaryocytes
Formin protein function has been investigated using knockout
mouse models, primarily for mDia1. Two independent labs have
created Diaph1 (mDia1) null mice (42,43). Both models are
apparently healthy and breed normally but display consistent
defects in white blood cells including lymphopenia, myeloproli-
ferative syndrome, myelodysplastic syndrome and reduced adhe-
sion, migration and chemotaxis of neutrophils and lymphocytes
(42–47). Studies on the platelets of the mDia1 knockout mice
revealed no major phenotype in terms of activation, aggregation
or spreading (33). We have tested platelet function following the
global inhibition of formin FH2 domains using the small mole-
cule inhibitor SMIFH2 and found that it blocks platelet spreading
and cytoskeletal organisation, indicating that formin activity is
required for platelet spreading (Thomas, Unpublished data). The
reason for the lack of phenotype in mDia1 KO platelets is unclear,
but is presumably due to functional redundancy with other formin
proteins; in the milieu of the activated platelet, it is highly likely
that the abundance of free actin barbed ends, profilin bound
G-actin and activated Rho family small GTPases allows for for-
min mediated actin assembly, even in the absence of one of the
formin family members. Alternatively, the lack of phenotype in
mDia1 KO platelets could be because mDia1 plays a very specific
minor role in the platelet or may primarily play a role in mega-
karyocytes which effects are carried over in platelets. These
functions may not manifest themselves during platelet activation,
but affect the resting platelet. Examples of these specific roles
include the organisation of actin filaments relative to microtu-
bules in the resting platelet or in regulating the balance of tubulin
post-translational modifications that influence microtubule
Figure 3. Expression of mammalian formin pro-
teins during megakaryocyte development.a)
Relative expression levels of the 15 mammalian
formin proteins during the development of
human megakaryocytes. CD34+ cells from
umbilical cord blood were cultured in vitro in
the presence of thrombopoietin and interleukin
1β and gene expression quantified by RNA-seq.
Data are taken from the Blueprint epigenome
project (http://www.blueprint-epigenome.eu/)
and (35). * Note – no data was available for the
expression of GRID2IP. b) Relative expression
levels of the 15 mammalian formin proteins
during the development of mouse megakaryo-
cytes. Bone marrow cells from C57BL/6 mice
were sorted using FACS and gene expression
quantified by microarrays. Data are taken from
the haemosphere database (http://haemosphere.
org/) and (36). For both panels, Log2 of nor-
malised gene expression is represented by a heat
map where red equals increased gene expres-
sion. Gene names in this figure and throughout
the review use the conventions of the HUGO
Gene Nomenclature Committee (www.gene-
names.org) and the Mouse Genome Informatics
(www.informatics.jax.org) for human and mouse
genes, respectively.
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stability and dynamics. This hypothesis is supported by the obser-
vation that in our hands, mDia1 knockout mice have an increased
platelet size, but normal platelet count (Thomas, Unpublished
data) indicating either a defect in platelet formation or an impair-
ment of the ability of the microtubule coil to maintain normal
platelet size. This hypothesis, however, remains to be tested.
mDia1 function has also been directly investigated in mega-
karyocytes. Pan et al. (48) used shRNA in human CD34+ derived
megakaryocytes to knockdown mDia1 expression to approxi-
mately 50–60% of controls. In these cells, proplatelet formation
(PPF) was increased, F-actin polymerisation was decreased and
the stability of microtubules was increased, as assessed by
increased Glu-tubulin (28,29). These data indicate that partial
inactivation of mDia1 activity in mature megakaryocytes is
required to allow proplatelet formation. This effect is proposed
to be mediated through reducing actin-myosin contractile forces
in the mature megakaryocyte which allows for the protrusion of
proplatelets, an effect also seen in inhibition of myosin IIa (48).
However, this effect may also be related to observed changes in
microtubule stability which could alter motor protein interaction
with microtubules facilitating proplatelet extension (49).
Intriguingly, platelet counts are normal in the mDia1 knockout
mouse (Thomas, Unpublished data) indicating a possible differ-
ence between human and mouse cells, or some compensatory
mechanism in the knockout. As indicated above, the mDia1
knockout platelets are increased in size (Thomas, Unpublished
data) suggesting that there is a defect in proplatelet formation/
release when mDia1 is absent. In addition, the knockdown experi-
ments performed by Pan et al. were done after megakaryocyte
differentiation, and so, the effect of reduced mDia1 expression on
human megakaryocyte development was not studied.
In addition to the loss of mDia1, Pan et al. also investigated
the expression of constitutively active (CA) mDia1 (just the FH1
and FH2 domains) (48). In these cells, a decrease in PPF forma-
tion, an increase in F-actin polymerisation and stress fibre forma-
tion was observed (48) which mirrored the results obtained in the
mDia1 knockdown cells. More recently, Stritt et al. have identi-
fied human patients with a gain of function mutation in the auto-
regulatory domain of DIAPH1 (R1213*) which leads to a con-
stitutively active protein (50). Patients with the R1213* variant
display macrothrombocytopenia and their platelets have abnormal
distributions and size of α-granules, vacuoles and membrane
complexes (50). Similar to that observed by Pan et al., the
R1213* variant caused a decrease in PPF in CD34+ derived
megakaryocytes providing support to the hypothesis that formin
mediated F-actin polymerisation can reduce proplatelet formation
due to actin-myosin contractile forces reducing protrusion (as
described above). It also indicates that proper regulation of formin
activity is required for correct delivery of granules, etc. to the
newly forming platelets.
A key difference between the two studies of CA mDia1 is
related to their effect on microtubule stability in megakaryocytes
and platelets. Pan et al. identified that CA mDia1 gave rise to
microtubules with decreased stability, whereas Stritt et al.
observed more stable microtubules. Indeed, the finding of Pan
seems to go against the general ability of FH1-FH2 domains to
increase microtubule stability (30,31). This difference may well
be due to the differences in the constitutively active mDia1 used;
the mDiaΔN3 used by Pan et al. has additional N terminal
deletions compared to the R1213* which may be important in
determining how formins interact with microtubules. For exam-
ple, loss of the Rho-GTPase binding domain in mDiaΔN3 CA
mDia1 may potentially cause it to be mis-localised and therefore
limit its ability to increase microtubule stabilisation. Likewise,
R1213* mDia1 may also lose the ability to be correctly localised
within the platelet which would affect its interaction with actin
and microtubules. Indeed, in patient platelets, R1213* variant
mDia1 displayed altered cellular localisation and gave rise to
increased F-actin content and disorganised microtubule organisa-
tion (50). Additional families with the R1213* mutation have
been identified and a further mutation in the auto-regulatory
domain of mDia1 has been reported (A1210Serfs*31), both of
which display thrombocytopenia (51) although the actin and
microtubule organisation has not been reported in these cases.
Finally, although there were clear differences in R1213* platelet
cytoskeletons, there was no observed difference in platelet aggre-
gation to a range of agonists (50). This data, taken in light of the
mDia1 knockout mouse phenotype, strongly suggest that mDia1
is redundant in platelet activation and its major role is in the
formation of platelets from the megakaryocyte.
Other formin family members in platelets and
megakaryocytes
Knockout mice have been generated for other formin proteins
(DAAM1, DAAM2, FMN2, mDia2, FHOD3 and INF2) and a
range of phenotypes described ranging from cardiac development
phenotypes (52–55), infertility (56,57), impaired red blood cell
production (58–60) and kidney development and function (61,62).
However, despite this, little is known about the effect of loss of
these formin proteins on megakaryocyte and platelet function. It
is likely that there is significant functional redundancy between
the formins or in megakaryocytes and platelets and so phenotypes
may be masked by the presence of other formin proteins.
Additionally, there may be genetic compensation for loss of
protein function which would supress the effect of a harmful
mutation (63). A systematic knockout of all four formins
expressed in megakaryocytes and platelets would help to answer
this but would be an expensive and complicated study. As can be
seen from the Stritt study (50), a useful avenue of research is
through identifying mutations in formin proteins that give rise to
thrombocytopenias and/or platelet function disorders via patient
genotyping studies. Many mutations will give rise to a protein
with an altered function, rather than complete loss of the protein
and so may allow more subtle phenotypes to be identified.
Future perspectives
As discussed above, the formins are an important family of actin and
microtubule regulatory proteins whose ability to i) nucleate and
elongate actin filaments, ii) bundle and organise both actin filaments
and microtubules and iii) regulate the stability and interactions of
microtubules, places them at the centre of cellular cytoskeletal
organisation. In relation to platelet function, global inhibition of
formins prevents platelet spreading indicating their importance in
platelet actin dynamics, however, as of yet, the precise contribution
of each of the expressed formins to platelet actin dynamics has yet to
be elucidated. In terms of the megakaryocyte, mDia1 has been
shown to be important for proper platelet formation, with changes
in platelet size, number or morphology being reported for both loss
and over-activation of mDia1. Thus, mDia1 likely mediates platelet
both the actin and tubulin cytoskeletons during platelet formation
where actin-myosin contractility and stable microtubules for propla-
telet extension need to be carefully balanced. The roles of Daam1,
Fhod1 and INF2 in platelets and megakaryocytes remain to be
determined and will require either knockout mouse models, identi-
fication of disease causing mutations or induced pluripotent stem
cell line studies to understand their functions.
The different classes expressed in megakaryocytes and platelets
suggest that they may be playing different roles in the function of
these cells. Furthermore, the upstream signalling proteins that acti-
vate formins are different depending on the formin (e.g. mDia1 is
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activated by RhoA, Fhod1 by ROCK and Rac1 and Daam1 by
binding to Dvl). These differences indicate that formins may be
involved with different processes or in different subcellular localisa-
tions in megakaryocytes and platelets which remain to be uncov-
ered. In addition, the downstream effects of formin activation may
be specific. For example, mDia1 has been demonstrated to be
required for formation of the mother actin filaments upon which
ARP2/3 complex can generate lamellipodial protrusions (64) and
studies reviewed here have highlighted their key role in coordinat-
ing microtubule dynamics. Thus, this may be a mechanism by
which mDia1 specifically coordinates the initiation of proplatelet
extensions, whereas other formins may regulate different megakar-
yocyte developmental pathways, for example, regulating the actin
pool during endomitosis. In addition, the demonstration that profilin
can regulate platelet microtubule dynamics most likely via its
interaction with formin proteins (65) highlights the complex and
important role that formins may have in regulating actin and micro-
tubules in megakaryocytes and platelets. It is also known that the
3D environment and particularly matrix stiffness is important for
regulating megakaryocytes and platelet function (66). Recent obser-
vations that mDia1:RhoA can act as a major biochemical switch for
mechanosensing/mechanotransduction (67) highlights that in the
physiological environment formins may be more important for
proper function and as such strides should be taken towards study-
ing them within bone marrow megakaryocytes or within platelets in
thrombi. Studies such as these will be important as we consider the
causes of uncharacterised thrombocytopenias and bleeding dia-
theses in patients or as we strive to improve the in vitro production
of platelets for clinical use, where subtle modifications of proteins
that regulate proplatelet formation could increase platelet yields or
quality.
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